Respiratory Innovation Wales Limited (RIW) is building Wales’ reputation as a recognised global Centre of Excellence in the development of innovative solutions to respiratory diseases. At its core is creating better health outcomes through the trial and delivery of new improved drugs, therapies and devices, innovative new health and care pathways, delivery of early diagnostic technologies and, ultimately, prevention.

RIW uniquely provides a single point of access to the NHS in Wales and a central focus for NHS, Academia, Industry and Patients for research and implementation of innovative solutions to respiratory health and wellbeing challenges. Its Executive team and Board hold a national remit for all 3.2 million people in Wales, however, the company will ensure solutions can be delivered at scale to global markets. To aid this, our partnerships with Respiratory invested organisations bring experience and expertise from discovery to commercialisation thus providing investment, structure and skills valuable to our NHS.

The RIW team consists of experienced private sector leadership and globally renowned experts from the NHS and partner universities. These include clinicians, R&D specialists and researchers.

By creating a new ecosystem with faster contracting and widespread contacts, RIW uniquely bridges multiple organisations in Wales. We secure time-limited projects and larger strategic partnerships along five major domains:

Our unique access to patients and an innovative and efficient R&D process is overseen by a dedicated contracts manager, highly experienced in respiratory trials, and supported by a mobile team of research staff. We deliver at speed Phase I to IV trials across all Wales in both secondary and primary care. We provide a single point of access for single or multiple sites and our projects include multi-phase and adaptive trials. We focus on doing the basics brilliantly and ensuring a smooth delivery of service.
A dedicated trials manager and senior clinical lead work alongside companies, manufacturers and clinicians to embed test and retest devices in real-world systems. RIW provides flexible access to relevant patients at speed and co-creates with partners innovative trial solutions. We are developing short and long-term collaborations across our Health and Social care systems – providing enough scale for those wishing to develop and test novel respiratory products.
A clinical lead runs our joined-up data systems covering over 70% of all General Practices and all hospitals through the MRC supported SAIL Databank with The Farr Institute. We can identify potential trial participants and predict health care benefits of interventions, with a powerful asset being linked biobank and outcome data for eventual personalised respiratory medicine.
The first Welsh repositories are just coming online and RIW is central to linking these to NHS Health Informatics across a homogenous and stable population.
RIW develops bespoke CPD programs for health professionals and industry locally and internationally. Co-created with industry, we deliver professional development courses that deliver meaningful ‘client led’ outcomes.

Our partners are provided with immediate access to a network of senior respiratory clinicians, R&D policy makers and academic groups. Our current expertise includes digital, nanotech, metabolomics, drug design, 3D printing and Prudent Value-based Healthcare and associated analysis. The company is supported by digital infrastructure encompassing leading edge digital platforms and technologies. Digital innovation forms a key part of our strategy.

RIW also allows access to initiatives funded by UK Government’s Industrial Strategy such as the Llanelli Wellness Village which combines a research, innovation and Wellbeing campus with clinical services (supporting the 5 stages of life approach) and biopharma. We also work closely with the new Health Campus developments in Swansea, the Rural Health Collaborative and the North Wales Innovation Centre.

For more information about our services and ecosystem partners please contact:

Sir Mansel Aylward CB
Chairman

Professor Sir Mansel Aylward CB is the first-ever Chair of Public Health Wales – a new unified NHS Trust responsible for the delivery of public health services at national, local and community level in Wales.  He was Chair of the Wales Centre for Health, an Assembly Government Sponsored Body established to be the ‘hub of connected organisations’ and to communicate better health messages to the people of Wales.  He is currently Chair of Public Health Wales – a unified NHS Trust responsible for the delivery of public health services at national, local and community level in Wales.

He is also Director of the Centre for Psychosocial and Disability Research at Cardiff University which offers a unique opportunity to extend knowledge and understanding of the psychosocial, economic and cultural factors that influence health, illness, recovery, rehabilitation and reintegration.

Professor Sir Mansel Aylward CB was knighted in the Queen’s New Year’s Honours 2010 for services to health and healthcare.

Kevin Smith
Chief Executive

Kevin is a serial medtech and consumer entrepreneur having co-founded numerous companies over the last 19 years.

Technology companies such as iPulse Limited, TrakCel Limited, Cellnovo Limited and Calon Cardio Limited along with lifestyle business Hemmels employ well over 200 people and have a combined revenue exceeding £50m. Kevin has been instrumental in raising significant investment funding and delivering global partnerships with companies such as Proctor & Gamble and GSK.

Kevin is advisor to Welsh Government on its Life Science and Cell & Gene Therapy strategies, entrepreneur in residence at Swansea University’s School of Management and Chairman of Gofal Enterprises, a subsidiary of mental health charity Gofal.

Prof Keir Lewis
Medical Director

Keir Lewis is Professor of Respiratory Medicine in Swansea University and a Consultant Physician and Director of Research & Development in Hywel Dda University Health Board, Wales.

He is a member of various research committees and task forces and has advised the British and European Thoracic Societies, Welsh Government, DISCHR, NICE and the HTA. He is an Associate Editor, and has written various papers and two textbooks. He is a Chief Investigator and/or collaborator in several ongoing research projects on the clinical and translational aspects of chronic obstructive pulmonary disease and smoking cessation.

Working with local universities, pharmaceutical and biomedical companies, he has helped attract over £3M funding and previously won the MediWales Innovation in the NHS Collaboration with International Industry awards.

The Board

Professor Keith Harding

Dean of Clinical Innovation at Cardiff University and Medical Director of the Welsh Wound Innovation Centre.

Professor Trevor Jones CBE

Chairman of the international Clinical Research Organisation, Simbec-Orion and Board member of the Global Life Sciences investment company; Arix Bioscience; the Oxford based Drug Discovery Company, e-Therapeutics; and the UK Stem Cell Foundation (UKSCF).

Professor Sue Bale OBE

Professor Sue Bale is R&D Director at the Aneurin Bevan Health Board. She also holds a Chair at the University of South Wales and at Cardiff University.

Sue has a career in wound healing research and has published widely over the past 36 years. She is currently the President of the European Wound Management Association.  In 2004 Sue received recognition for her services to wound healing when the Royal College of Nursing conferred on her a Fellowship for her ‘Outstanding contribution to nursing research, development and practice of wound care in the UK and internationally’.  More recently in 2014, she was invested with an OBE by her Majesty the Queen for ‘Services to nursing and nursing research’.

Sue has worked in the Welsh Government for the Chief Nursing Officer for Wales on Clinical Academic Career pathways, developing policy for building research capacity and career paths for nurses and Allied Health Professionals.

Professor Keith Harding

Dean of Clinical Innovation at Cardiff University and Medical Director of the Welsh Wound Innovation Centre.

Professor Trevor Jones CBE

Chairman of the international Clinical Research Organisation, Simbec-Orion and Board member of the Global Life Sciences investment company; Arix Bioscience; the Oxford based Drug Discovery Company, e-Therapeutics; and the UK Stem Cell Foundation (UKSCF).

Professor Sue Bale OBE

Professor Sue Bale is R&D Director at the Aneurin Bevan Health Board. She also holds a Chair at the University of South Wales and at Cardiff University.

Sue has a career in wound healing research and has published widely over the past 36 years. She is currently the President of the European Wound Management Association.  In 2004 Sue received recognition for her services to wound healing when the Royal College of Nursing conferred on her a Fellowship for her ‘Outstanding contribution to nursing research, development and practice of wound care in the UK and internationally’.  More recently in 2014, she was invested with an OBE by her Majesty the Queen for ‘Services to nursing and nursing research’.

Sue has worked in the Welsh Government for the Chief Nursing Officer for Wales on Clinical Academic Career pathways, developing policy for building research capacity and career paths for nurses and Allied Health Professionals.

Our Partners include:

The Beacon Centre for Enterprise, Dafen, Llanelli, Carmarthenshire SA14 8LQ, UK

© 2018 Respiratory Innovation Wales / Website by Accent Creative